Novartis Highlights Innovation Focus and Regulatory Data Protection in India
Novartis, marking 25 years of its major research and development hub in India, is focusing on innovation and shifting away from traditional generics. Judith Love, president for Asia-Pacific, Middle East, and Africa, highlighted the company's long-term commitment to India, emphasizing the importance of regulatory data protection and strong intellectual property rights to enhance India's attractiveness for pharmaceutical innovation and manufacturing. Discussions with the Indian government are ongoing to support these goals.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (64/100). Lens Score 40/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 7 Sept, 12:40 am. Other outlets followed.